The impact of mindfulness training in early adolescence on affective executive control, and on later mental health during the COVID-19 pandemic: a randomised controlled trial.

child & adolescent psychiatry

Journal

Evidence-based mental health
ISSN: 1468-960X
Titre abrégé: Evid Based Ment Health
Pays: England
ID NLM: 100883413

Informations de publication

Date de publication:
12 Jul 2022
Historique:
received: 24 02 2022
accepted: 15 06 2022
entrez: 12 7 2022
pubmed: 13 7 2022
medline: 13 7 2022
Statut: aheadofprint

Résumé

Previous research suggests that mindfulness training (MT) appears effective at improving mental health in young people. MT is proposed to work through improving executive control in affectively laden contexts. However, it is unclear whether MT improves such control in young people. MT appears to mitigate mental health difficulties during periods of stress, but any mitigating effects against COVID-related difficulties remain unexamined. To evaluate whether MT (intervention) versus psychoeducation (Psy-Ed; control), implemented in after-school classes: (1) Improves affective executive control; and/or (2) Mitigates negative mental health impacts from the COVID-19 pandemic. A parallel randomised controlled trial (RCT) was conducted (Registration: https://osf.io/d6y9q/; Funding: Wellcome (WT104908/Z/14/Z, WT107496/Z/15/Z)). 460 students aged 11-16 years were recruited and randomised 1:1 to either MT (N=235) or Psy-Ed (N=225) and assessed preintervention and postintervention on experimental tasks and self-report inventories of affective executive control. The RCT was then extended to evaluate protective functions of MT on mental health assessed after the first UK COVID-19 lockdown. Results provided no evidence that the version of MT used here improved affective executive control after training or mitigated negative consequences on mental health of the COVID-19 pandemic relative to Psy-Ed. No adverse events were reported. There is no evidence that MT improves affective control or downstream mental health of young people during stressful periods. We need to identify interventions that can enhance affective control and thereby young people's mental health.

Sections du résumé

BACKGROUND BACKGROUND
Previous research suggests that mindfulness training (MT) appears effective at improving mental health in young people. MT is proposed to work through improving executive control in affectively laden contexts. However, it is unclear whether MT improves such control in young people. MT appears to mitigate mental health difficulties during periods of stress, but any mitigating effects against COVID-related difficulties remain unexamined.
OBJECTIVE OBJECTIVE
To evaluate whether MT (intervention) versus psychoeducation (Psy-Ed; control), implemented in after-school classes: (1) Improves affective executive control; and/or (2) Mitigates negative mental health impacts from the COVID-19 pandemic.
METHODS METHODS
A parallel randomised controlled trial (RCT) was conducted (Registration: https://osf.io/d6y9q/; Funding: Wellcome (WT104908/Z/14/Z, WT107496/Z/15/Z)). 460 students aged 11-16 years were recruited and randomised 1:1 to either MT (N=235) or Psy-Ed (N=225) and assessed preintervention and postintervention on experimental tasks and self-report inventories of affective executive control. The RCT was then extended to evaluate protective functions of MT on mental health assessed after the first UK COVID-19 lockdown.
FINDINGS RESULTS
Results provided no evidence that the version of MT used here improved affective executive control after training or mitigated negative consequences on mental health of the COVID-19 pandemic relative to Psy-Ed. No adverse events were reported.
CONCLUSIONS CONCLUSIONS
There is no evidence that MT improves affective control or downstream mental health of young people during stressful periods.
CLINICAL IMPLICATIONS CONCLUSIONS
We need to identify interventions that can enhance affective control and thereby young people's mental health.

Identifiants

pubmed: 35820991
pii: ebmental-2022-300460
doi: 10.1136/ebmental-2022-300460
pmc: PMC9340025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/V027751/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00030/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00005/14
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105579212
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Investigateurs

Ruth Baer (R)
Daniel Brett (D)
Eleanor-Rose Farley (ER)
Triona Casey (T)
Nicola Dalrymple (N)
Katherine De Wilde (K)
Katie Fletcher (K)
Jennifer Harper (J)
Verena Hinze (V)
Nils Kapplemann (N)
Maria Kempnich (M)
Konstantina Komnindou (K)
Suzannah Laws (S)
Liz Lord (L)
Emma Medlicott (E)
Lucy Palmer (L)
Ariane Petit (A)
Alice Phillips (A)
Isobel Pryor-Nitsch (I)
Lucy Radley (L)
Anam Raja (A)
Elsie Sellars (E)
Jem Shackleford (J)
Anna Sonley (A)
Laura Taylor (L)
Alice Tickell (A)
Lucy Warriner (L)
Sarah Byford (S)
Mark Greenberg (M)
Tamsin Ford (T)
Susan Gathercole (S)
Russell Viner (R)
Phil Zelazo (P)
Rachel Knight (R)
Blanca Piera Pi-Sunyer (BP)
Kirsten Thomas (K)
Susan Ball (S)
Poushali Ganguli Ben Jones (PG)
Nick Allen (N)
Susan Bogels (S)
Pim Cuijpers (P)
Celene Domitrovich (C)
Uta Frith (U)
Terrie Moffitt (T)
Vikram Patel (V)

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: WK is the Director of the Oxford Mindfulness Centre and receives royalties for several books on mindfulness. JMGW is former Director of the Oxford Mindfulness Centre and receives royalties for several books on mindfulness.

Références

BMJ. 2021 Mar 10;372:n614
pubmed: 33692087
Evid Based Ment Health. 2022 Jul 12;:
pubmed: 35820993
Arch Gen Psychiatry. 2002 Oct;59(10):877-83
pubmed: 12365874
Clin Psychol Rev. 2011 Aug;31(6):1032-40
pubmed: 21802618
PLoS One. 2011;6(9):e24372
pubmed: 21949712
Perspect Psychol Sci. 2011 Nov;6(6):537-59
pubmed: 26168376
Trends Cogn Sci. 2008 Apr;12(4):163-9
pubmed: 18329323
J Educ Psychol. 1967 Jun;58(3):129-36
pubmed: 6043849
Evid Based Ment Health. 2022 Jul 12;:
pubmed: 35820992
J Neurosci. 2013 Mar 20;33(12):5301-11
pubmed: 23516294
Annu Rev Psychol. 2017 Jan 3;68:491-516
pubmed: 27687118
J Youth Adolesc. 1991 Apr;20(2):149-66
pubmed: 24265004
Emotion. 2020 Feb;20(1):80-86
pubmed: 31961183
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
J Child Psychol Psychiatry. 2019 Mar;60(3):244-258
pubmed: 30345511
Psychol Assess. 2011 Sep;23(3):606-14
pubmed: 21480722
Br J Psychiatry. 2013 Aug;203(2):126-31
pubmed: 23787061
J Abnorm Psychol. 2000 Aug;109(3):504-11
pubmed: 11016119
Behav Res Ther. 2000 Aug;38(8):835-55
pubmed: 10937431
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Lancet Public Health. 2018 Feb;3(2):e72-e81
pubmed: 29422189
Cogn Affect Behav Neurosci. 2008 Mar;8(1):54-64
pubmed: 18405046
Neuropsychologia. 1997 Jun;35(6):747-58
pubmed: 9204482

Auteurs

Darren Dunning (D)

Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK.

S Ahmed (S)

Institute of Cognitive Neuroscience, University College London, London, UK.

L Foulkes (L)

Institute of Cognitive Neuroscience, University College London, London, UK.

C Griffin (C)

Institute of Cognitive Neuroscience, University College London, London, UK.

K Griffiths (K)

Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK.

J T Leung (JT)

Institute of Cognitive Neuroscience, University College London, London, UK.

J Parker (J)

Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK.

Blanca Piera Pi-Sunyer (B)

Institute of Cognitive Neuroscience, University College London, London, UK.

A Sakhardande (A)

Institute of Cognitive Neuroscience, University College London, London, UK.

M Bennett (M)

Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK.

C Haag (C)

Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK.

Jesus Montero-Marin (J)

Teaching, Research and Innovation Unit, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, UK.

D Packman (D)

College of Medicine and Health, University of Exeter, Exeter, UK.

Maris Vainre (M)

Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK.

P Watson (P)

Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK.

Willem Kuyken (W)

Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, UK.

J Mark G Williams (JMG)

Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, UK.

Obioha C Ukoumunne (OC)

NIHR CLAHRC South West Peninsula, University of Exeter Medical School, Exeter, UK.

Sarah-Jayne Blakemore (SJ)

Institute of Cognitive Neuroscience, University College London, London, UK.
Department of Psychology, University of Cambridge, Cambridge, UK.

Tim Dalgleish (T)

Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK tim.dalgleish@mrc-cbu.cam.ac.uk.

Classifications MeSH